These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1633979)

  • 1. The relationship between 111In-labelled immunoscintigraphy and serum CA-125 levels in ovarian carcinoma patients postchemotherapy.
    Prosser ES; Pomeroy M; Barker F; Carroll K; Davis M; Duffy J; Duffy G; Fennelly JJ; O'Kennedy R
    Biochem Soc Trans; 1992 Feb; 20(1):54S. PubMed ID: 1633979
    [No Abstract]   [Full Text] [Related]  

  • 2. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
    Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
    Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
    Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
    Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
    J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
    Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
    J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
    Peking A; Marinov V
    Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in serological, immunoscintigraphic and immunocytochemical diagnosis of epithelial ovarian cancer.
    Branconi F; Amunni G; Bonazza M; Villanucci A; Veneziano AE; Massi GB
    Eur J Gynaecol Oncol; 1989; 10(4):262-7. PubMed ID: 2776783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoscintigraphy of oncologic tumors].
    Barzen G
    Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.
    Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D
    Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comprehensive diagnosis of cancer of the ovaries].
    Korsunskiĭ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
    Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
    Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
    Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.
    Hunter RE; Doherty P; Griffin TW; Gionet M; Hnatowich DJ; Bianco JA; Dillon MB
    Gynecol Oncol; 1987 Jul; 27(3):325-39. PubMed ID: 3497845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA 125, CA 15.3 and CA 19.9 levels and surgical findings in patients undergoing second look operations for ovarian carcinomas.
    Barrenetxea G; Martin-Mateos M; Barzazan MJ; Montoya F; Matia JC; Rodriguez-Escudero FJ
    Eur J Gynaecol Oncol; 1990; 11(5):369-74. PubMed ID: 2097153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodiagnosis of ovarian tumors.
    Jacobs I; Bast RC
    Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoscintigraphy of ovarian endometriosis. A preliminary study.
    Kennedy SH; Soper ND; Mojiminiyi OA; Shepstone BJ; Barlow DH
    Br J Obstet Gynaecol; 1988 Jul; 95(7):693-7. PubMed ID: 3166379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors.
    Li XG; Chen DX; Schwartz PE; Yang Z
    Gynecol Oncol; 1989 Mar; 32(3):327-30. PubMed ID: 2920953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
    Low RN; Carter WD; Saleh F; Sigeti JS
    Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.